Annexin I Antibodies

Santa Cruz Biotechnology delivers a wide array of Annexin I monoclonal antibodies for research focused on understanding cellular processes. Annexin I monoclonal antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Annexin I plays a vital role in regulating cellular processes, including apoptosis, inflammation, and membrane trafficking. The phospholipid-binding capabilities of Annexin I are essential for maintaining cellular homeostasis and mediating cell signaling pathways. Research has shown that Annexin I significantly influences the development and progression of various diseases, including cancer and autoimmune disorders. Investigating Annexin I expression and activity patterns helps reveal its impact on cellular function and disease mechanisms. Understanding the relationship between Annexin I and cellular responses provides valuable insights into potential therapeutic approaches. Examining Annexin I interactions with other molecules advances knowledge of signaling cascades and regulatory networks. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Annexin I's role in health and disease.